Mylan Obtains CHMP Backing For Revlimid Generic In Two Indications

Accord Already Holds Final Approval For Lenalidomide Generic

 
• By Dean Rudge

Mylan is taking aim at a lucrative oral solid formulation in Europe, with the European Medicines Agency’s Committee for Medicinal Products for Human Use recommending approval for the company’s generic version of Revlimid (lenalidomide) capsules.

3d render of Europe map Earth globe
Mylan's generic lenalidomide product was backed by the CHMP • Source: Shutterstock

More from Generics

More from Products